The information in this preliminary pricing supplement is not
complete and may be changed. This preliminary pricing supplement is
not an offer to sell nor does it seek an offer to buy these
securities in any jurisdiction where the offer or sale is not
permitted.
Subject to completion dated December 8, 2022
December ,
2022 |
Registration Statement Nos. 333-236659
and 333-236659-01; Rule 424(b)(2) |

JPMorgan Chase Financial Company LLC
Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF due June 26, 2025
Fully and Unconditionally Guaranteed by JPMorgan
Chase & Co.
|
· |
The notes are designed for investors who seek a capped return
of 2.00 times any appreciation (with a Maximum Upside Return of at
least 30.00%) of the iShares® MSCI EAFE ETF at
maturity. |
|
· |
The notes are also designed for investors who seek a
capped, unleveraged return equal to the absolute value of any
depreciation of the Fund at maturity (up to 25.00%) if the
Final Value is greater than or equal to 75.00% of the Initial
Value, which we refer to as the Barrier Amount. |
|
· |
Investors should be willing to forgo interest and dividend
payments and be willing to lose some or all of their principal
amount at maturity. |
|
· |
The notes are unsecured and unsubordinated obligations of
JPMorgan Chase Financial Company LLC, which we refer to as JPMorgan
Financial, the payment on which is fully and unconditionally
guaranteed by JPMorgan Chase & Co. Any payment on the notes
is subject to the credit risk of JPMorgan Financial, as issuer of
the notes, and the credit risk of JPMorgan Chase & Co., as
guarantor of the notes. |
|
· |
Minimum denominations of $1,000 and integral multiples
thereof |
|
· |
The notes are expected to price on or about December 21, 2022
and are expected to settle on or about December 27, 2022. |
Investing in the notes involves a number of risks. See “Risk
Factors” beginning on page S-2 of the accompanying prospectus
supplement, “Risk Factors” beginning on page PS-12 of the
accompanying product supplement, “Risk Factors” beginning on page
US-3 of the accompanying underlying supplement and “Selected Risk
Considerations” beginning on page PS-4 of this pricing
supplement.
Neither the Securities and Exchange Commission (the “SEC”) nor any
state securities commission has approved or disapproved of the
notes or passed upon the accuracy or the adequacy of this pricing
supplement or the accompanying product supplement, underlying
supplement, prospectus supplement and prospectus. Any
representation to the contrary is a criminal offense.
|
Price to Public (1) |
Fees and Commissions (2) |
Proceeds to Issuer |
Per note |
$1,000 |
$ |
$ |
Total |
$ |
$ |
$ |
(1) See “Supplemental Use of Proceeds” in this pricing supplement
for information about the components of the price to public of the
notes.
(2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting
as agent for JPMorgan Financial, will pay all of the selling
commissions it receives from us to other affiliated or unaffiliated
dealers. In no event will these selling commissions exceed $21.00
per $1,000 principal amount note. See “Plan of Distribution
(Conflicts of Interest)” in the accompanying product
supplement.
|
If the notes priced today, the estimated value of the notes
would be approximately $955.80 per $1,000 principal amount note.
The estimated value of the notes, when the terms of the notes are
set, will be provided in the pricing supplement and will not be
less than $940.00 per $1,000 principal amount note. See “The
Estimated Value of the Notes” in this pricing supplement for
additional information.
The notes are not bank deposits, are not insured by the Federal
Deposit Insurance Corporation or any other governmental agency and
are not obligations of, or guaranteed by, a bank.
Pricing supplement to product supplement no. 4-II dated November 4,
2020, underlying supplement no. 1-II dated November 4, 2020
and the prospectus and prospectus supplement, each dated April 8,
2020
Key Terms
Issuer:
JPMorgan Chase Financial Company
LLC, an indirect, wholly owned finance subsidiary of JPMorgan Chase
& Co.
Guarantor:
JPMorgan Chase & Co.
Fund:
The iShares® MSCI EAFE
ETF (Bloomberg ticker: EFA)
Maximum
Upside Return: At least
30.00% (corresponding to a maximum payment at maturity if the Fund
Return is positive of at least $1,300.00 per $1,000 principal
amount note) (to be provided in the pricing supplement)
Upside Leverage Factor:
2.00
Barrier Amount:
75.00% of the Initial Value
Pricing
Date: On or about December 21, 2022
Original
Issue Date (Settlement Date): On or about December 27, 2022
Observation
Date*: June 23, 2025
Maturity
Date*: June 26, 2025
* Subject to postponement in the event of a market disruption
event and as described under
“General Terms of Notes — Postponement of a Determination Date —
Notes Linked to a Single Underlying — Notes Linked to a Single
Underlying (Other Than a Commodity Index)” and “General Terms of
Notes — Postponement of a Payment Date” in the accompanying product
supplement
|
Payment at Maturity:
If the
Final Value is greater than the Initial Value, your payment at
maturity per $1,000 principal amount note will be calculated as
follows:
$1,000 + ($1,000 × Fund Return × Upside Leverage Factor), subject
to the Maximum Upside Return
If the Final Value is equal to the Initial Value or is less than
the Initial Value but greater than or equal to the Barrier Amount,
your payment at maturity per $1,000 principal amount note will be
calculated as follows:
$1,000 + ($1,000 × Absolute Fund Return)
This payout formula results in an effective cap of 25.00% on
your return at maturity if the Fund Return is negative. Under these
limited circumstances, your maximum payment at maturity is
$1,250.00 per $1,000 principal amount note.
If the Final Value is less than the Barrier Amount, your payment at
maturity per $1,000 principal amount note will be calculated as
follows:
$1,000 + ($1,000 × Fund Return)
If the Final Value is less than the Barrier Amount, you will
lose more than 25.00% of your principal amount at maturity and
could lose all of your principal amount at maturity.
Absolute
Fund Return: The absolute value of the Fund Return. For
example, if the Fund Return is -5%, the Absolute Fund Return will
equal 5%.
Fund Return:
(Final Value – Initial Value)
Initial Value
Initial Value:
The closing price of one share of
the Fund on the Pricing Date
Final
Value: The closing price
of one share of the Fund on the Observation Date
Share
Adjustment Factor: The Share Adjustment Factor is
referenced in determining the closing price of one share of the
Fund and is set equal to 1.0 on the Pricing Date. The Share
Adjustment Factor is subject to adjustment upon the occurrence of
certain events affecting the Fund. See “The Underlyings — Funds —
Anti-Dilution Adjustments” in the accompanying product supplement
for further information.
|
PS-1
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
Hypothetical Payout Profile
The following table and graph illustrate the hypothetical total
return and payment at maturity on the notes linked to a
hypothetical Fund. The “total return” as used in this pricing
supplement is the number, expressed as a percentage, that results
from comparing the payment at maturity per $1,000 principal amount
note to $1,000. The hypothetical total returns and payments set
forth below assume the following:
|
· |
an Initial Value of $100.00; |
|
· |
a Maximum Upside Return of 30.00%; |
|
· |
an Upside Leverage Factor of 2.00; and |
|
· |
a Barrier Amount of $75.00 (equal to 75.00% of the hypothetical
Initial Value). |
The hypothetical Initial Value of $100.00 has been chosen for
illustrative purposes only and may not represent a likely actual
Initial Value. The actual Initial Value will be the closing price
of one share of the Fund on the Pricing Date and will be provided
in the pricing supplement. For historical data regarding the actual
closing prices of one share of the Fund, please see the historical
information set forth under “The Fund” in this pricing
supplement.
Each hypothetical total return or hypothetical payment at maturity
set forth below is for illustrative purposes only and may not be
the actual total return or payment at maturity applicable to a
purchaser of the notes. The numbers appearing in the following
table and graph have been rounded for ease of analysis.
Final Value |
Fund Return |
Absolute Fund Return |
Total Return on the
Notes |
Payment at Maturity |
$180.00 |
80.00% |
N/A |
30.00% |
$1,300.00 |
$165.00 |
65.00% |
N/A |
30.00% |
$1,300.00 |
$150.00 |
50.00% |
N/A |
30.00% |
$1,300.00 |
$140.00 |
40.00% |
N/A |
30.00% |
$1,300.00 |
$130.00 |
30.00% |
N/A |
30.00% |
$1,300.00 |
$120.00 |
20.00% |
N/A |
30.00% |
$1,300.00 |
$115.00 |
15.00% |
N/A |
30.00% |
$1,300.00 |
$110.00 |
10.00% |
N/A |
20.00% |
$1,200.00 |
$105.00 |
5.00% |
N/A |
10.00% |
$1,100.00 |
$101.00 |
1.00% |
N/A |
2.00% |
$1,020.00 |
$100.00 |
0.00% |
0.00% |
0.00% |
$1,000.00 |
$95.00 |
-5.00% |
5.00% |
5.00% |
$1,050.00 |
$90.00 |
-10.00% |
10.00% |
10.00% |
$1,100.00 |
$80.00 |
-20.00% |
20.00% |
20.00% |
$1,200.00 |
$75.00 |
-25.00% |
25.00% |
25.00% |
$1,250.00 |
$74.99 |
-25.01% |
N/A |
-25.01% |
$749.90 |
$70.00 |
-30.00% |
N/A |
-30.00% |
$700.00 |
$60.00 |
-40.00% |
N/A |
-40.00% |
$600.00 |
$50.00 |
-50.00% |
N/A |
-50.00% |
$500.00 |
$40.00 |
-60.00% |
N/A |
-60.00% |
$400.00 |
$30.00 |
-70.00% |
N/A |
-70.00% |
$300.00 |
$20.00 |
-80.00% |
N/A |
-80.00% |
$200.00 |
$10.00 |
-90.00% |
N/A |
-90.00% |
$100.00 |
$0.00 |
-100.00% |
N/A |
-100.00% |
$0.00 |
PS-2
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
The following graph demonstrates the hypothetical total returns and
hypothetical payments at maturity on the notes for a sub-set of
Fund Returns detailed in the table above (-80% to 80%). There can
be no assurance that the performance of the Fund will result in the
return of any of your principal amount.

How the Notes Work
Fund Upside Scenario:
If the Final Value is greater than the Initial Value, investors
will receive at maturity the $1,000 principal amount plus a
return equal to the Fund Return times the Upside Leverage
Factor of 2.00, subject to the Maximum Upside Return of at least
30.00%. Assuming a hypothetical Maximum Upside Return of 30.00%, an
investor will realize the maximum upside payment at maturity at a
Final Value of 115.00% or more of the Initial Value.
|
· |
If the closing price of one share of the Fund increases 5.00%,
investors will receive at maturity a 10.00% return, or $1,100.00
per $1,000 principal amount note. |
|
· |
Assuming a hypothetical Maximum Upside Return of 30.00%, if the
closing price of one share of the Fund increases 50.00%, investors
will receive at maturity a return equal to the 30.00% Maximum
Upside Return, or $1,300.00 per $1,000 principal amount note, which
is the maximum payment at maturity if the Fund Return is
positive. |
Fund Par or Fund Depreciation Upside Scenario:
If the Final Value is equal to the Initial Value or is less than
the Initial Value but greater than or equal to the Barrier Amount
of 75.00% of the Initial Value, investors will receive at maturity
the $1,000 principal amount plus a return equal to the
Absolute Fund Return.
|
· |
For example, if the closing price of one share of the Fund
declines 10.00%, investors will receive at maturity a 10.00%
return, or $1,100.00 per $1,000 principal amount note. |
Downside Scenario:
If the Final Value is less than the Barrier Amount of 75.00% of the
Initial Value, investors will lose 1% of the principal amount of
their notes for every 1% that the Final Value is less than the
Initial Value.
|
· |
For example, if the closing price of one share of the Fund
declines 60.00%, investors will lose 60.00% of their principal
amount and receive only $400.00 per $1,000 principal amount note at
maturity. |
The hypothetical returns and hypothetical payments on the notes
shown above apply only if you hold the notes for their entire
term. These hypotheticals do not reflect the fees or expenses
that would be associated with any sale in the secondary market. If
these fees and expenses were included, the hypothetical returns and
hypothetical payments shown above would likely be lower.
PS-3
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
Selected Risk Considerations
An investment in the notes involves significant risks. These risks
are explained in more detail in the “Risk Factors” sections of the
accompanying prospectus supplement, product supplement and
underlying supplement.
Risks Relating to the Notes Generally
|
· |
YOUR INVESTMENT IN THE NOTES MAY RESULT IN A LOSS — |
The notes do not guarantee any return of principal. If the Final
Value is less than the Barrier Amount, you will lose 1% of the
principal amount of your notes for every 1% that the Final Value is
less than the Initial Value. Accordingly, under these
circumstances, you will lose more than 25.00% of your principal
amount at maturity and could lose all of your principal amount at
maturity.
|
· |
YOUR MAXIMUM GAIN ON THE NOTES IS LIMITED TO THE MAXIMUM
UPSIDE RETURN IF THE FUND RETURN IS POSITIVE, |
regardless of the appreciation of the Fund, which may be
significant.
|
· |
YOUR MAXIMUM GAIN ON THE NOTES IS LIMITED BY THE BARRIER
AMOUNT IF THE FUND RETURN IS NEGATIVE — |
Because the payment at maturity will not reflect the Absolute Fund
Return if the Final Value is less than the Barrier Amount, the
Barrier Amount effectively caps your return at maturity if the Fund
Return is negative. The maximum payment at maturity if the Fund
Return is negative is $1,250.00 per $1,000 principal amount
note.
|
· |
CREDIT RISKS OF JPMORGAN FINANCIAL AND JPMORGAN CHASE &
CO. — |
Investors are dependent on our and JPMorgan Chase & Co.’s
ability to pay all amounts due on the notes. Any actual or
potential change in our or JPMorgan Chase & Co.’s
creditworthiness or credit spreads, as determined by the market for
taking that credit risk, is likely to adversely affect the value of
the notes. If we and JPMorgan Chase & Co. were to default on
our payment obligations, you may not receive any amounts owed to
you under the notes and you could lose your entire investment.
|
· |
AS A FINANCE SUBSIDIARY, JPMORGAN FINANCIAL HAS NO
INDEPENDENT OPERATIONS AND HAS LIMITED ASSETS — |
As a finance subsidiary of JPMorgan Chase & Co., we have no
independent operations beyond the issuance and administration of
our securities. Aside from the initial capital contribution from
JPMorgan Chase & Co., substantially all of our assets relate to
obligations of our affiliates to make payments under loans made by
us or other intercompany agreements. As a result, we are dependent
upon payments from our affiliates to meet our obligations under the
notes. If these affiliates do not make payments to us and we fail
to make payments on the notes, you may have to seek payment under
the related guarantee by JPMorgan Chase & Co., and that
guarantee will rank pari passu with all other unsecured and
unsubordinated obligations of JPMorgan Chase & Co.
|
· |
THE BENEFIT PROVIDED BY THE BARRIER AMOUNT MAY TERMINATE ON
THE OBSERVATION DATE — |
If the Final Value is less than the Barrier Amount, the benefit
provided by the Barrier Amount will terminate, and you will be
fully exposed to any depreciation of the Fund.
|
· |
THE NOTES DO NOT PAY INTEREST. |
|
· |
YOU WILL NOT RECEIVE DIVIDENDS ON THE FUND OR THE SECURITIES
HELD BY THE FUND OR HAVE ANY RIGHTS WITH RESPECT TO THE FUND OR
THOSE SECURITIES. |
|
· |
THE RISK OF THE CLOSING PRICE OF ONE SHARE OF THE FUND
FALLING BELOW THE BARRIER AMOUNT IS GREATER IF THE PRICE OF ONE
SHARE OF THE FUND IS VOLATILE. |
The notes will not be listed on any securities exchange.
Accordingly, the price at which you may be able to trade your notes
is likely to depend on the price, if any, at which JPMS is willing
to buy the notes. You may not be able to sell your notes. The notes
are not designed to be short-term trading instruments. Accordingly,
you should be able and willing to hold your notes to maturity.
|
· |
THE FINAL TERMS AND VALUATION OF THE NOTES WILL BE PROVIDED
IN THE PRICING SUPPLEMENT — |
You should consider your potential investment in the notes based on
the minimums for the estimated value of the notes and the Maximum
Upside Return.
PS-4
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
Risks Relating to Conflicts of Interest
We and our affiliates play a variety of roles in connection with
the notes. In performing these duties, our and JPMorgan Chase &
Co.’s economic interests are potentially adverse to your interests
as an investor in the notes. It is possible that hedging or trading
activities of ours or our affiliates in connection with the notes
could result in substantial returns for us or our affiliates while
the value of the notes declines. Please refer to “Risk Factors —
Risks Relating to Conflicts of Interest” in the accompanying
product supplement.
Risks Relating to the Estimated Value and Secondary Market
Prices of the Notes
|
· |
THE ESTIMATED VALUE OF THE NOTES WILL BE LOWER THAN THE
ORIGINAL ISSUE PRICE (PRICE TO PUBLIC) OF THE NOTES — |
The estimated value of the notes is only an estimate determined by
reference to several factors. The original issue price of the notes
will exceed the estimated value of the notes because costs
associated with selling, structuring and hedging the notes are
included in the original issue price of the notes. These costs
include the selling commissions, the projected profits, if any,
that our affiliates expect to realize for assuming risks inherent
in hedging our obligations under the notes and the estimated cost
of hedging our obligations under the notes. See “The Estimated
Value of the Notes” in this pricing supplement.
|
· |
THE ESTIMATED VALUE OF THE NOTES DOES NOT REPRESENT FUTURE
VALUES OF THE NOTES AND MAY DIFFER FROM OTHERS’ ESTIMATES
— |
See “The Estimated Value of the Notes” in this pricing
supplement.
|
· |
THE ESTIMATED VALUE OF THE NOTES IS DERIVED BY REFERENCE TO
AN INTERNAL FUNDING RATE — |
The internal funding rate used in the determination of the
estimated value of the notes may differ from the market-implied
funding rate for vanilla fixed income instruments of a similar
maturity issued by JPMorgan Chase & Co. or its affiliates. Any
difference may be based on, among other things, our and our
affiliates’ view of the funding value of the notes as well as the
higher issuance, operational and ongoing liability management costs
of the notes in comparison to those costs for the conventional
fixed income instruments of JPMorgan Chase & Co. This internal
funding rate is based on certain market inputs and assumptions,
which may prove to be incorrect, and is intended to approximate the
prevailing market replacement funding rate for the notes. The use
of an internal funding rate and any potential changes to that rate
may have an adverse effect on the terms of the notes and any
secondary market prices of the notes. See “The Estimated Value of
the Notes” in this pricing supplement.
|
· |
THE VALUE OF THE NOTES AS PUBLISHED BY JPMS (AND WHICH MAY
BE REFLECTED ON CUSTOMER ACCOUNT STATEMENTS) MAY BE HIGHER THAN THE
THEN-CURRENT ESTIMATED VALUE OF THE NOTES FOR A LIMITED TIME PERIOD
— |
We generally expect that some of the costs included in the original
issue price of the notes will be partially paid back to you in
connection with any repurchases of your notes by JPMS in an amount
that will decline to zero over an initial predetermined period. See
“Secondary Market Prices of the Notes” in this pricing supplement
for additional information relating to this initial period.
Accordingly, the estimated value of your notes during this initial
period may be lower than the value of the notes as published by
JPMS (and which may be shown on your customer account
statements).
|
· |
SECONDARY MARKET PRICES OF THE NOTES WILL LIKELY BE LOWER
THAN THE ORIGINAL ISSUE PRICE OF THE NOTES — |
Any secondary market prices of the notes will likely be lower than
the original issue price of the notes because, among other things,
secondary market prices take into account our internal secondary
market funding rates for structured debt issuances and, also,
because secondary market prices may exclude selling commissions,
projected hedging profits, if any, and estimated hedging costs that
are included in the original issue price of the notes. As a result,
the price, if any, at which JPMS will be willing to buy the notes
from you in secondary market transactions, if at all, is likely to
be lower than the original issue price. Any sale by you prior to
the Maturity Date could result in a substantial loss to you.
|
· |
SECONDARY MARKET PRICES OF THE NOTES WILL BE IMPACTED BY
MANY ECONOMIC AND MARKET FACTORS — |
The secondary market price of the notes during their term will be
impacted by a number of economic and market factors, which may
either offset or magnify each other, aside from the selling
commissions, projected hedging profits, if any, estimated hedging
costs and the price of one share of the Fund. Additionally,
independent pricing vendors and/or third party broker-dealers may
publish a price for the notes, which may also be reflected on
customer account statements. This price may be different (higher or
lower) than the price of the notes, if any, at which JPMS may be
willing to purchase your notes in the secondary market. See
“Risk
PS-5
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
Factors — Risks Relating to the Estimated Value and Secondary
Market Prices of the Notes — Secondary market prices of the notes
will be impacted by many economic and market factors” in the
accompanying product supplement.
Risks Relating to the Fund
|
· |
THERE ARE RISKS ASSOCIATED WITH THE FUND — |
The Fund is subject to management risk, which is the risk that the
investment strategies of the Fund’s investment adviser, the
implementation of which is subject to a number of constraints, may
not produce the intended results. These constraints could adversely
affect the market price of the shares of the Fund and,
consequently, the value of the notes.
|
· |
THE PERFORMANCE AND MARKET VALUE OF THE FUND, PARTICULARLY
DURING PERIODS OF MARKET VOLATILITY, MAY NOT CORRELATE WITH THE
PERFORMANCE OF THE FUND’S UNDERLYING INDEX AS WELL AS THE NET ASSET
VALUE PER SHARE — |
The Fund does not fully replicate its Underlying Index (as defined
under “The Fund” below) and may hold securities different from
those included in its Underlying Index. In addition, the
performance of the Fund will reflect additional transaction costs
and fees that are not included in the calculation of its Underlying
Index. All of these factors may lead to a lack of correlation
between the performance of the Fund and its Underlying Index. In
addition, corporate actions with respect to the equity securities
underlying the Fund (such as mergers and spin-offs) may impact the
variance between the performances of the Fund and its Underlying
Index. Finally, because the shares of the Fund are traded on a
securities exchange and are subject to market supply and investor
demand, the market value of one share of the Fund may differ from
the net asset value per share of the Fund.
During periods of market volatility, securities underlying the Fund
may be unavailable in the secondary market, market participants may
be unable to calculate accurately the net asset value per share of
the Fund and the liquidity of the Fund may be adversely affected.
This kind of market volatility may also disrupt the ability of
market participants to create and redeem shares of the Fund.
Further, market volatility may adversely affect, sometimes
materially, the prices at which market participants are willing to
buy and sell shares of the Fund. As a result, under these
circumstances, the market value of shares of the Fund may vary
substantially from the net asset value per share of the Fund. For
all of the foregoing reasons, the performance of the Fund may not
correlate with the performance of its Underlying Index as well as
the net asset value per share of the Fund, which could materially
and adversely affect the value of the notes in the secondary market
and/or reduce any payment on the notes.
|
· |
NON-U.S. SECURITIES RISK — |
The equity securities held by the Fund have been issued by non-U.S.
companies. Investments in securities linked to the value of
such non-U.S. equity securities involve risks associated with the
securities markets in the home countries of the issuers of those
non-U.S. equity securities. Also, there is generally less
publicly available information about companies in some of these
jurisdictions than there is about U.S. companies that are subject
to the reporting requirements of the SEC.
|
· |
THE NOTES ARE SUBJECT TO CURRENCY EXCHANGE RISK — |
Because the prices of the equity
securities held by the Fund are converted into U.S. dollars for
purposes of calculating the net asset value of the Fund,
holders of the notes will be exposed to currency exchange rate risk
with respect to each of the currencies in which the equity
securities held by the Fund trade. Your net exposure will depend on
the extent to which those currencies strengthen or weaken against
the U.S. dollar and the relative weight of equity securities held
by the Fund denominated in each of those currencies. If, taking
into account the relevant weighting, the U.S. dollar strengthens
against those currencies, the price of the Fund will be adversely
affected and any payment on the notes may be reduced.
|
· |
THE ANTI-DILUTION PROTECTION FOR THE FUND IS LIMITED
— |
The calculation agent will make adjustments to the Share Adjustment
Factor for certain events affecting the shares of the Fund.
However, the calculation agent will not make an adjustment in
response to all events that could affect the shares of the Fund. If
an event occurs that does not require the calculation agent to make
an adjustment, the value of the notes may be materially and
adversely affected.
PS-6
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
The Fund is an exchange-traded fund of iShares® Trust, a
registered investment company, that seeks to track the investment
results, before fees and expenses, of an index composed of large-
and mid-capitalization developed market equities, excluding the
United States and Canada, which we refer to as the Underlying Index
with respect to the Fund. The Underlying Index for the Fund is
currently the MSCI EAFE® Index. The MSCI
EAFE® Index is a free float-adjusted market
capitalization index intended to measure the equity market
performance of certain developed markets, excluding the United
States and Canada. For additional information about the Fund, see
“Fund Descriptions — The iShares® ETFs” in the
accompanying underlying supplement.
Historical Information
The following graph sets forth the historical performance of the
Fund based on the weekly historical closing prices of one share of
the Fund from January 6, 2017 through December 2, 2022. The closing
price of one share of the Fund on December 7, 2022 was $66.53. We
obtained the closing prices above and below from the Bloomberg
Professional® service (“Bloomberg”), without independent
verification. The closing prices above and below may have been
adjusted by Bloomberg for actions taken by the Fund, such as stock
splits.
The historical closing prices of one share of the Fund should not
be taken as an indication of future performance, and no assurance
can be given as to the closing price of one share of the Fund on
the Pricing Date or the Observation Date. There can be no assurance
that the performance of the Fund will result in the return of any
of your principal amount.

Tax Treatment
You should review carefully
the section entitled “Material U.S. Federal Income Tax
Consequences” in the accompanying product supplement no. 4-II. The
following discussion, when read in combination with that section,
constitutes the full opinion of our special tax counsel, Davis Polk
& Wardwell LLP, regarding the material U.S. federal income tax
consequences of owning and disposing of notes.
Based on current market
conditions, in the opinion of our special tax counsel it is
reasonable to treat the notes as “open transactions” that are not
debt instruments for U.S. federal income tax purposes, as more
fully described in “Material U.S. Federal Income Tax Consequences —
Tax Consequences to U.S. Holders — Notes Treated as Open
Transactions That Are Not Debt Instruments” in the accompanying
product supplement. Assuming this treatment is respected, subject
to the possible application of the “constructive ownership” rules,
the gain or loss on your notes should be treated as long-term
capital gain or loss if you hold your notes for more than a year,
whether or not you are an initial purchaser of notes at the issue
price. The notes could be treated as “constructive ownership
transactions” within the meaning of Section 1260 of the Code, in
which case any gain recognized in respect of the notes that would
otherwise be long-term capital gain and that was in excess of the
“net underlying long-term capital gain” (as defined in Section
1260) would be treated as ordinary income, and a notional interest
charge would apply as if that income had accrued for tax purposes
at a constant yield over your holding period for the notes. Our
special tax counsel has not expressed an opinion with respect to
whether the constructive ownership rules apply to the notes.
Accordingly, U.S. Holders should consult their tax advisers
regarding the potential application of the constructive ownership
rules.
The IRS or a court may not
respect the treatment of the notes described above, in which case
the timing and character of any income or loss on your notes could
be materially and adversely affected. In addition, in 2007 Treasury
and the IRS released a notice
PS-7
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
requesting comments on the U.S. federal income tax treatment of
“prepaid forward contracts” and similar instruments. The notice
focuses in particular on whether to require investors in these
instruments to accrue income over the term of their investment. It
also asks for comments on a number of related topics, including the
character of income or loss with respect to these instruments; the
relevance of factors such as the nature of the underlying property
to which the instruments are linked; the degree, if any, to which
income (including any mandated accruals) realized by non-U.S.
investors should be subject to withholding tax; and whether these
instruments are or should be subject to the constructive ownership
regime described above. While the notice requests comments on
appropriate transition rules and effective dates, any Treasury
regulations or other guidance promulgated after consideration of
these issues could materially and adversely affect the tax
consequences of an investment in the notes, possibly with
retroactive effect. You should consult your tax adviser regarding
the U.S. federal income tax consequences of an investment in the
notes, including the potential application of the constructive
ownership rules, possible alternative treatments and the issues
presented by this notice.
Section 871(m) of the Code
and Treasury regulations promulgated thereunder (“Section 871(m)”)
generally impose a 30% withholding tax (unless an income tax treaty
applies) on dividend equivalents paid or deemed paid to Non-U.S.
Holders with respect to certain financial instruments linked to
U.S. equities or indices that include U.S. equities. Section 871(m)
provides certain exceptions to this withholding regime, including
for instruments linked to certain broad-based indices that meet
requirements set forth in the applicable Treasury regulations.
Additionally, a recent IRS notice excludes from the scope of
Section 871(m) instruments issued prior to January 1, 2025 that do
not have a delta of one with respect to underlying securities that
could pay U.S.-source dividends for U.S. federal income tax
purposes (each an “Underlying Security”). Based on certain
determinations made by us, we expect that Section 871(m) will not
apply to the notes with regard to Non-U.S. Holders. Our
determination is not binding on the IRS, and the IRS may disagree
with this determination. Section 871(m) is complex and its
application may depend on your particular circumstances, including
whether you enter into other transactions with respect to an
Underlying Security. If necessary, further information regarding
the potential application of Section 871(m) will be provided in the
pricing supplement for the notes. You should consult your tax
adviser regarding the potential application of Section 871(m) to
the notes.
The Estimated Value of the Notes
The estimated value of the notes set forth on the cover of this
pricing supplement is equal to the sum of the values of the
following hypothetical components: (1) a fixed-income debt
component with the same maturity as the notes, valued using the
internal funding rate described below, and (2) the derivative or
derivatives underlying the economic terms of the notes. The
estimated value of the notes does not represent a minimum price at
which JPMS would be willing to buy your notes in any secondary
market (if any exists) at any time. The internal funding rate used
in the determination of the estimated value of the notes may differ
from the market-implied funding rate for vanilla fixed income
instruments of a similar maturity issued by JPMorgan Chase &
Co. or its affiliates. Any difference may be based on, among other
things, our and our affiliates’ view of the funding value of the
notes as well as the higher issuance, operational and ongoing
liability management costs of the notes in comparison to those
costs for the conventional fixed income instruments of JPMorgan
Chase & Co. This internal funding rate is based on certain
market inputs and assumptions, which may prove to be incorrect, and
is intended to approximate the prevailing market replacement
funding rate for the notes. The use of an internal funding rate and
any potential changes to that rate may have an adverse effect on
the terms of the notes and any secondary market prices of the
notes. For additional information, see “Selected Risk
Considerations — Risks Relating to the Estimated Value and
Secondary Market Prices of the Notes — The Estimated Value of the
Notes Is Derived by Reference to an Internal Funding Rate” in this
pricing supplement.
The value of the derivative or derivatives underlying the economic
terms of the notes is derived from internal pricing models of our
affiliates. These models are dependent on inputs such as the traded
market prices of comparable derivative instruments and on various
other inputs, some of which are market-observable, and which can
include volatility, dividend rates, interest rates and other
factors, as well as assumptions about future market events and/or
environments. Accordingly, the estimated value of the notes is
determined when the terms of the notes are set based on market
conditions and other relevant factors and assumptions existing at
that time.
The estimated value of the notes does not represent future values
of the notes and may differ from others’ estimates. Different
pricing models and assumptions could provide valuations for the
notes that are greater than or less than the estimated value of the
notes. In addition, market conditions and other relevant factors in
the future may change, and any assumptions may prove to be
incorrect. On future dates, the value of the notes could change
significantly based on, among other things, changes in market
conditions, our or JPMorgan Chase & Co.’s creditworthiness,
interest rate movements and other relevant factors, which may
impact the price, if any, at which JPMS would be willing to buy
notes from you in secondary market transactions.
The estimated value of the notes will be lower than the original
issue price of the notes because costs associated with selling,
structuring and hedging the notes are included in the original
issue price of the notes. These costs include the selling
commissions paid to JPMS and other affiliated or unaffiliated
dealers, the projected profits, if any, that our affiliates expect
to realize for assuming risks inherent in hedging our obligations
under the notes and the estimated cost of hedging our obligations
under the notes. Because
PS-8
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
hedging our obligations entails risk and may be influenced by
market forces beyond our control, this hedging may result in a
profit that is more or less than expected, or it may result in a
loss. A portion of the profits, if any, realized in hedging our
obligations under the notes may be allowed to other affiliated or
unaffiliated dealers, and we or one or more of our affiliates will
retain any remaining hedging profits. See “Selected Risk
Considerations — Risks Relating to the Estimated Value and
Secondary Market Prices of the Notes — The Estimated Value of the
Notes Will Be Lower Than the Original Issue Price (Price to Public)
of the Notes” in this pricing supplement.
Secondary Market Prices of the Notes
For information about factors that will impact any secondary market
prices of the notes, see “Risk Factors — Risks Relating to the
Estimated Value and Secondary Market Prices of the Notes —
Secondary market prices of the notes will be impacted by many
economic and market factors” in the accompanying product
supplement. In addition, we generally expect that some of the costs
included in the original issue price of the notes will be partially
paid back to you in connection with any repurchases of your notes
by JPMS in an amount that will decline to zero over an initial
predetermined period. These costs can include selling commissions,
projected hedging profits, if any, and, in some circumstances,
estimated hedging costs and our internal secondary market funding
rates for structured debt issuances. This initial predetermined
time period is intended to be the shorter of six months and
one-half of the stated term of the notes. The length of any such
initial period reflects the structure of the notes, whether our
affiliates expect to earn a profit in connection with our hedging
activities, the estimated costs of hedging the notes and when these
costs are incurred, as determined by our affiliates. See “Selected
Risk Considerations — Risks Relating to the Estimated Value and
Secondary Market Prices of the Notes — The Value of the Notes as
Published by JPMS (and Which May Be Reflected on Customer Account
Statements) May Be Higher Than the Then-Current Estimated Value of
the Notes for a Limited Time Period” in this pricing
supplement.
Supplemental Use of Proceeds
The notes are offered to meet investor demand for products that
reflect the risk-return profile and market exposure provided by the
notes. See “Hypothetical Payout Profile” and “How the Notes Work”
in this pricing supplement for an illustration of the risk-return
profile of the notes and “The Fund” in this pricing supplement for
a description of the market exposure provided by the notes.
The original issue price of the notes is equal to the estimated
value of the notes plus the selling commissions paid to JPMS and
other affiliated or unaffiliated dealers, plus (minus) the
projected profits (losses) that our affiliates expect to realize
for assuming risks inherent in hedging our obligations under the
notes, plus the estimated cost of hedging our obligations under the
notes.
Supplemental Plan of Distribution
We expect that delivery of the
notes will be made against payment for the notes on or about the
Original Issue Date set forth on the front cover of this pricing
supplement, which will be the third business day following the
Pricing Date of the notes (this settlement cycle being referred to
as “T+3”). Under Rule 15c6-1 of the Securities Exchange Act of
1934, as amended, trades in the secondary market generally are
required to settle in two business days, unless the parties to that
trade expressly agree otherwise. Accordingly, purchasers who wish
to trade notes on any date prior to two business days before
delivery will be required to specify an alternate settlement cycle
at the time of any such trade to prevent a failed settlement and
should consult their own advisors.
Supplemental Notice to Investors
The notes may cause you to become subject to short position
disclosure requirements if they confer a financial advantage on you
in the event of a decrease in the price or value of any relevant
shares under Regulation (EU) No. 236/2012 (the “Short Selling
Regulation"). This will occur if the short position represented by
the short exposure provided by the notes, when combined with other
long and short positions you may hold, causes you to cross a
relevant net short position disclosure threshold under the Short
Selling Regulation. It is your responsibility to monitor your net
short positions and to comply with the obligations applicable to
you under the Short Selling Regulation. You should consult with
your own legal and regulatory advisers regarding the notes should
you have any concerns about these requirements.
Supplemental Information About the Form of the Notes
The notes will initially be represented by a type of global
security that we refer to as a master note. A master note
represents multiple securities that may be issued at different
times and that may have different terms. The trustee and/or
paying agent will, in accordance with instructions from us, make
appropriate entries or notations in its records relating to the
master note representing the notes to indicate that the master note
evidences the notes.
PS-9
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
Additional Terms Specific to the Notes
You may revoke your offer to purchase the notes at any time prior
to the time at which we accept such offer by notifying the
applicable agent. We reserve the right to change the terms of, or
reject any offer to purchase, the notes prior to their issuance. In
the event of any changes to the terms of the notes, we will notify
you and you will be asked to accept such changes in connection with
your purchase. You may also choose to reject such changes, in which
case we may reject your offer to purchase.
You should read this pricing supplement together with the
accompanying prospectus, as supplemented by the accompanying
prospectus supplement relating to our Series A medium-term notes of
which these notes are a part, and the more detailed information
contained in the accompanying product supplement and the
accompanying underlying supplement. This pricing supplement,
together with the documents listed below, contains the terms of the
notes and supersedes all other prior or contemporaneous oral
statements as well as any other written materials including
preliminary or indicative pricing terms, correspondence, trade
ideas, structures for implementation, sample structures, fact
sheets, brochures or other educational materials of ours. You
should carefully consider, among other things, the matters set
forth in the “Risk Factors” sections of the accompanying prospectus
supplement, the accompanying product supplement and the
accompanying underlying supplement, as the notes involve risks not
associated with conventional debt securities. We urge you to
consult your investment, legal, tax, accounting and other advisers
before you invest in the notes.
You may access these documents on the SEC website at www.sec.gov as
follows (or if such address has changed, by reviewing our filings
for the relevant date on the SEC website):
Our Central Index Key, or CIK, on the SEC website is 1665650, and
JPMorgan Chase & Co.’s CIK is 19617. As used in this pricing
supplement, “we,” “us” and “our” refer to JPMorgan Financial.
PS-10
| Structured Investments
Capped Dual Directional Accelerated Barrier Notes Linked to the
iShares® MSCI EAFE ETF
|
 |
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Feb 2023 to Mar 2023
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
From Mar 2022 to Mar 2023